Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Hasenclever

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
ErbB-3 predicts survival in ovarian cancerBerno Tanner, Dirk Hasenclever, Katja Stern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 studyAndreas Engert, Volker Diehl, Jeremy Franklin, et al.
Gastroenterology|May 3, 2017
Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without BiopsyJohannes Wolf, David Petroff, Thomas Richter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2020
Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive DiseaseRegine Kluge, Tim Wittig, Thomas W Georgi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 studyChristine Mauz-Körholz, Dirk Hasenclever, Wolfgang Dörffel, et al.
Plos One|March 11, 2016
Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's LymphomaRegine Kluge, Lidia Chavdarova, Martha Hoffmann, et al.
British Journal of Haematology|November 20, 2008
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphomaInga Vater, Florian Wagner, Markus Kreuz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trialAndreas Engert, Jeremy Franklin, Hans Theodor Eich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2003
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study GroupAndreas Engert, Petra Schiller, Andreas Josting, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphomaSandra Purz, Christine Mauz-Körholz, Dieter Körholz, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
ErbB-3 predicts survival in ovarian cancerBerno Tanner, Dirk Hasenclever, Katja Stern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 studyAndreas Engert, Volker Diehl, Jeremy Franklin, et al.
Gastroenterology|May 3, 2017
Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without BiopsyJohannes Wolf, David Petroff, Thomas Richter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2020
Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive DiseaseRegine Kluge, Tim Wittig, Thomas W Georgi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 studyChristine Mauz-Körholz, Dirk Hasenclever, Wolfgang Dörffel, et al.
Plos One|March 11, 2016
Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's LymphomaRegine Kluge, Lidia Chavdarova, Martha Hoffmann, et al.
British Journal of Haematology|November 20, 2008
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphomaInga Vater, Florian Wagner, Markus Kreuz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trialAndreas Engert, Jeremy Franklin, Hans Theodor Eich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2003
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study GroupAndreas Engert, Petra Schiller, Andreas Josting, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphomaSandra Purz, Christine Mauz-Körholz, Dieter Körholz, et al.
Pageof 10